CST

Clifford Law Offices Hosts 17th Annual Free CLE Program

Retrieved on: 
Thursday, February 8, 2024
CLE, Continuing legal education, CST, Ethics, Faculty, University, Senior counsel, Robert A. Clifford, Supreme court, Circuit court, Trench

CHICAGO, Feb. 8, 2024 /PRNewswire-PRWeb/ -- Clifford Law Offices will host its 17th annual free Continuing Legal Education webinar on Thursday, February 15, 2024. The two-hour webcast program will begin at 2:30 pm CST and will be free and open to the public.

Key Points: 
  • The 17th Annual Clifford Law Offices Free Continuing Legal Education Webinar will be held on Thursday, February 15, 2024
    CHICAGO, Feb. 8, 2024 /PRNewswire-PRWeb/ -- Clifford Law Offices will host its 17th annual free Continuing Legal Education webinar on Thursday, February 15, 2024.
  • The two-hour webcast program will begin at 2:30 pm CST and will be free and open to the public.
  • The firm welcomes legal professionals, law students, and anyone else with interest to join the free webcast on the topic of "Ethics 2024: Questions from the Trenches."
  • The interactive program will be moderated by Robert A. Clifford , founder and senior partner at Clifford Law Offices, and feature panelists Kevin L. Hopkins, Brody-O'Neill Endowed Faculty Scholar, University of Illinois Chicago School of Law; Hon.

Sensient Technologies Corporation Reports Results for the Quarter Ended December 31, 2023

Retrieved on: 
Thursday, February 8, 2024
Health, Chemicals, Plastics, Manufacturing, Other Health, Fitness & Nutrition, Other Manufacturing, Biotechnology, Flavor, Ernst & Young, Transport, Color Group, Federal, Sensient Technologies, CST, Acquisition, Corporation, Business administration, Food industry, Growth, Earnout, GAAP, Annual report, Certified Public Accountant, Depreciation, Senior, Food, Fruit, Controller, Hamas, Yogurt, Video game

Segment operating income was $18.1 million in the fourth quarter of 2023, a decrease of $3.4 million compared to the prior year’s fourth quarter.

Key Points: 
  • Segment operating income was $18.1 million in the fourth quarter of 2023, a decrease of $3.4 million compared to the prior year’s fourth quarter.
  • Segment operating income was $21.3 million in the fourth quarter of 2023, a decrease of $3.2 million compared to the prior year’s fourth quarter results.
  • The Asia Pacific Group reported revenue of $33.2 million in the fourth quarter of 2023, a decrease of $1.4 million compared to the prior year’s fourth quarter.
  • Segment operating income was $5.9 million in the quarter, a decrease of $0.7 million compared to the prior year’s fourth quarter.

Baxter Reports Fourth-Quarter and Full-Year 2023 Results

Retrieved on: 
Thursday, February 8, 2024
Medical Supplies, Health, Medical Devices, General Health, Pharmaceutical, Optical, Biotechnology, EPS, Task force, DNA, Nursing care plan, Piperacillin, Noise, Corporate social responsibility, FDA, Corporation, Medicine, UN, Dow Jones, EMR, Failure, Baxter International, Growth, Perioperative, TCFD, DJSI, Patient, Tazobactam, Centrella, Skin, Thrombin, Risk, Warburg Pincus, Acute liver failure, Galaxy, PD, NuVasive, Peritoneal dialysis, Risk management, Advent International, BPS, Sale, Eye, CST, Pharmaceutical industry

Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2023, and provided its financial guidance for full-year and first-quarter 2024.

Key Points: 
  • Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2023, and provided its financial guidance for full-year and first-quarter 2024.
  • For full-year 2023, net income attributable to Baxter on a U.S. GAAP basis totaled $2.66 billion, or $5.25 per diluted share.
  • In 2023, the company was named to the Dow Jones Sustainability Index (DJSI) North America, which has included Baxter each year since it launched in 2005.
  • For full-year 2024: Baxter expects sales growth of approximately 2% on both a reported and constant currency basis.

Adverum Biotechnologies Announces Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Trial of Ixo-vec in Patients with Wet AMD

Retrieved on: 
Thursday, February 8, 2024
Chorioretinitis, Injection, Principal, Inflammation, Life, Adverum Biotechnologies, VEGF, AMD, Partner (business rank), Vasculitis, Patient, Safety, Paratriathlon, Prednisone, University of Nevada, Reno, Intraocular pressure, Data, Webcast, University, Retinitis, M.A, Clinical research, CST, Vascular occlusion, Pharmaceutical industry

These data are being presented by Dr. Arshad Khanani today at the 47th Annual Meeting of the Macula Society.

Key Points: 
  • These data are being presented by Dr. Arshad Khanani today at the 47th Annual Meeting of the Macula Society.
  • “Wet AMD is a leading cause of blindness in people over the age of 65, requiring life-long anti-VEGF injections.
  • Our goal with Ixo-vec is to provide patients virtually injection-free management of their wet AMD lasting years and potentially for life,” stated Laurent Fischer, M.D., president and chief executive officer of Adverum Biotechnologies.
  • The LUNA trial builds on our experience with the OPTIC study, where landmark 2-year data was recently published in The Lancet’s eclinicalmedicine.

LiveWire Group, Inc. Reports 2023 Fourth Quarter and Full Year Financial Results

Retrieved on: 
Thursday, February 8, 2024
Motorcycles, EV, Electric Vehicles, Alternative Vehicles, Fuels, Automotive, Other Automotive, Automotive Manufacturing, Vehicle Technology, Manufacturing, Livewire, Scooter (motorcycle), Engineering, CST, Video game

The Company’s consolidated net loss was $109.6 million for the year ended 2023 compared to $78.9 million for the year ended 2022.

Key Points: 
  • The Company’s consolidated net loss was $109.6 million for the year ended 2023 compared to $78.9 million for the year ended 2022.
  • LiveWire Group, Inc. is comprised of two business segments:
    Electric Motorcycle revenue increased in fourth quarter 2023 compared to the same quarter in the prior year due to sales of Del Mar units.
  • STACYC volumes were up in the fourth quarter of 2023 compared to 2022, while revenue and operating income were down due to product mix and pricing.
  • LiveWire leadership will be joining the Harley-Davidson, Inc. audio webcast to discuss our results, developments in the business, and updates to the Company’s outlook.

The Toro Company to Announce Fiscal 2024 First Quarter Results

Retrieved on: 
Wednesday, February 7, 2024
Landscape, Automotive, Home Goods, Other Natural Resources, Other Retail, Other Construction & Property, Agriculture, Natural Resources, Other Manufacturing, Construction & Property, Specialty, Automotive Manufacturing, Manufacturing, Building Systems, Retail, Other Automotive, Performance & Special Interest, The Toro Company, TTC, CST

The Toro Company (NYSE: TTC), a leading global provider of solutions for the outdoor environment, announced today that it will release its fiscal 2024 first quarter results on Thursday, March 7, at approximately 7:30 a.m. CST.

Key Points: 
  • The Toro Company (NYSE: TTC), a leading global provider of solutions for the outdoor environment, announced today that it will release its fiscal 2024 first quarter results on Thursday, March 7, at approximately 7:30 a.m. CST.
  • The full text of The Toro Company’s earnings release will be available at that time at www.thetorocompany.com/invest .
  • The company will also hold an earnings conference call at 10 a.m. CST that day.
  • For those unable to listen to the live webcast, a replay will be available at www.thetorocompany.com/invest .

Sleep Number Corporation to Announce Fourth Quarter and Full Year 2023 Results on February 22nd

Retrieved on: 
Wednesday, February 7, 2024
Home Goods, Other Retail, Specialty, Consumer Electronics, Technology, Online Retail, Luxury, Retail, Sleep, EST, Webcast, CST

Sleep Number Corporation (Nasdaq: SNBR) will release its fourth quarter and full year results through December 30, 2023, after market close on Thursday, February 22, 2024.

Key Points: 
  • Sleep Number Corporation (Nasdaq: SNBR) will release its fourth quarter and full year results through December 30, 2023, after market close on Thursday, February 22, 2024.
  • Management will host its regularly scheduled conference call to discuss the company’s results at 5 p.m. EST (4 p.m. CST; 2 p.m. PST).
  • To access the webcast, please visit the investor relations area of the Sleep Number website at https://ir.sleepnumber.com .
  • The webcast replay will remain available for approximately 60 days.

Internationally renowned filmmaker Rory Kennedy coming to Canada this weekend for Film Training Manitoba’s Film Master Series, Kennedy available for interviews

Retrieved on: 
Wednesday, February 7, 2024
The Washington Post, CNN, Today (American TV program), Interview, Sundance Film Festival, The Daily Show, Netflix, National Geographic, PBS, FTM, Los Angeles Times, The New York Times, HBO, MITT, CST, Woman, Film industry

“Rory Kennedy is one of the world’s foremost documentary filmmakers with a stellar and exceptional body of work,” said Film Training Manitoba’s Executive Director Adam Smoluk.

Key Points: 
  • “Rory Kennedy is one of the world’s foremost documentary filmmakers with a stellar and exceptional body of work,” said Film Training Manitoba’s Executive Director Adam Smoluk.
  • He added, “This is a rare opportunity for Manitoba film professionals to learn from the very best the industry has to offer.
  • Pre-event one-on-one online interviews with Rory Kennedy are available by appointment on Thursday, February 8 from 3:00 pm – 5:00 pm CST.
  • There may be the possibility that Rory Kennedy might be available for limited interviews outside this time frame by arrangement.

ADAMEVE.COM ASKS "DO YOU BELIEVE OVER-THE-COUNTER ABORTION PILLS SHOULD BE LEGALLY AVAILABLE TO WOMEN IN THE UNITED STATES?"

Retrieved on: 
Tuesday, February 6, 2024
Multimedia, LMFT, Marketing, Mifepristone, Planned Parenthood, Condom, Human, Abortion, Adam and Eve, Doctor of Philosophy, Parenthood, CST, Woman, Birth control

This month, the company surveyed over 1000 people asking if over-the-counter abortion pills should be legally available to women in the U.S. And the responses may surprise you.

Key Points: 
  • This month, the company surveyed over 1000 people asking if over-the-counter abortion pills should be legally available to women in the U.S. And the responses may surprise you.
  • Currently available only from a doctor, nurse, health clinic or Planned Parenthood, the mifepristone and/or misoprostol pills cause an "at-home abortion" that is considered both safe and effective.
  • While just over 49% of those surveyed felt that over-the-counter abortion pills should be legally available to women under any circumstance, another 24% said they should be available under certain circumstance.
  • Nearly 20% of respondents said abortion pills should not be legally available, and an additional 7% said they weren't sure.

Hewlett Packard Enterprise to Present Live Audio Webcast of Fiscal 2024 First Quarter Earnings Conference Call

Retrieved on: 
Tuesday, February 6, 2024
Data Management, Consumer Electronics, Technology, Software, Artificial Intelligence, Hardware, Hewlett Packard Enterprise, Webcast, CST, HPE

Hewlett Packard Enterprise (NYSE: HPE) will conduct a live audio webcast of its conference call to review its financial results for the first quarter of fiscal 2024, which ended January 31, 2024.

Key Points: 
  • Hewlett Packard Enterprise (NYSE: HPE) will conduct a live audio webcast of its conference call to review its financial results for the first quarter of fiscal 2024, which ended January 31, 2024.
  • The call is scheduled for Thursday, February 29, at 4:30 p.m. CST (5:30 p.m.
  • ET), and the webcast will be available at www.hpe.com/investor/2024Q1Webcast .
  • A replay of the audio webcast will be available at the same website shortly after the call and will remain available for approximately one year.